2026 ICD-10-CM Diagnosis Code C86.60Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

ICD-10-CM Codes›C00–D49›C81-C96›C86

ICD-10-CM C86.60
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C86.60 is a billable ICD-10-CM diagnosis code for primary cutaneous CD30-positive T-cell proliferations not having achieved remission. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842, 974 through 976. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Non-Hodgkin lymphoma.

Code Identity

ICD-10-CM Code
C86.60
Billable Status
Yes — Valid for Submission
Code Describes
Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
Short Description
Primary cutaneous CD30-positive T-cell prolif not remission
Parent Code
C86.6
Primary cutaneous CD30-positive T-cell proliferations

Code Classification

ChapterC00–D49Neoplasms
SectionC81-C96Malignant neoplasms of lymphoid, hematopoietic and related tissue
CategoryC86Other specified types of T/NK-cell lymphoma
This CodeC86.60Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Anaplastic large cell lymphoma, T/Null cell, primary systemic type
  • CD-30 positive pleomorphic large T-cell cutaneous lymphoma
  • CD-30 positive T-immunoblastic cutaneous lymphoma
  • Hodgkin's disease affecting skin
  • Large cell anaplastic lymphoma T cell and null cell type
  • Lymphomatoid papulosis
  • Lymphomatoid papulosis type A
  • Lymphomatoid papulosis type B - mycosis fungoides-like
  • Lymphomatoid papulosis type C
  • Lymphomatoid papulosis with Hodgkin's disease
  • Lymphomatoid papulosis-associated mycosis fungoides
  • Primary cutaneous anaplastic large cell lymphoma
  • Primary cutaneous CD30 antigen positive T-cell lymphoproliferative disorder
  • Primary cutaneous CD30+ large T-cell lymphoma
  • Primary cutaneous large T-cell lymphoma
  • Primary cutaneous lymphoma

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Lymphomatoid papulosis NOS
  • Lymphomatoid papulosis not having achieved remission
  • Lymphomatoid papulosis with failed remission
  • Primary cutaneous anaplastic large cell lymphoma NOS
  • Primary cutaneous anaplastic large cell lymphoma not having achieved remission
  • Primary cutaneous anaplastic large cell lymphoma with failed remission
  • Primary cutaneous CD30-positive large T-cell lymphoma NOS
  • Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
  • Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
  • Primary cutaneous CD30-positive T-cell proliferations NOS
  • Primary cutaneous CD30-positive T-cell proliferations with failed remission

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO058
Non-Hodgkin lymphoma
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Lymphomatoid Papulosis

    clinically benign, histologically malignant, recurrent cutaneous t-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. the atypical cells resemble reed-sternberg cells of hodgkin disease or the malignant cells of cutaneous t-cell lymphoma. in some cases, lymphomatoid papulosis progresses to lymphomatous conditions including mycosis fungoides; hodgkin disease; cutaneous t-cell lymphoma; or anaplastic large-cell lymphoma.

Code History & ChangesHistory

Replacement C86.60 replaces the following previously assigned code(s):

  • C86.6 - Primary cutaneous CD30-positive T-cell proliferations
FY 2025AddedAdded to the ICD-10-CM code setEffective October 1, 2024.
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C86.60Overview

Is C86.60 (Primary cutaneous CD30-positive T-cell proliferations) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report primary cutaneous CD30-positive T-cell proliferations not having achieved remission on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C86.60 group to?

When primary cutaneous CD30-positive T-cell proliferations not having achieved remission is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, 974, 975, 976, with relative weights from 0.8945 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.